Malignant Cutaneous Neoplasms

Similar documents
Malignant Cutaneous Neoplasms. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

Living Beyond Cancer Skin Cancer Detection and Prevention

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Clinical characteristics

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Periocular Malignancies

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Periocular skin cancer

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Skin Malignancies. Presented by Dr. Douglas Paauw

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Disclosures. I have no conflicts of interest to disclose

Actinic keratosis (AK): Dr Sarma s simple guide

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

VACAVILLE DERMATOLOGY

General information about skin cancer

Malignant Melanoma Early Stage. A guide for patients

Identifying Benign and Malignant Skin Lesions. No Disclosures. Common Benign Lesions. Benign Lesions 2/25/2018. Stucco Keratoses.

Skin Cancer - Non-Melanoma

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Disclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose

Steven Robinson. Steven Robinson Memorial Endowment at

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer

Melanoma: The Basics. What is a melanocyte?

See spot change: Lesion identification and management in primary care ERIN HENNESSEY DNP, APRN, FNP-C

Case Presentation Protocol 2018 Hot Spots in Dermatology

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT

SKIN CANCER. Most common cancer diagnosis 40% of all cancers


Skin Cancer. There are many types of diseases. From a simple cold to the deadly disease

SKIN. 3. How is the skin structured around the finger joints to allow for flexible movement of the fingers?

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

Exenteration. Introduction. The skin. Epidermal malignancies 8/3/2017. Neglected basal cell carcinoma

Limit Direct Sun Exposure

Richard Turner Consultant Dermatologist

Oral and Maxillofacial Surgery Department

LPN2008 l Volume 4, Number 4

Skin Cancer Awareness

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 13, :30 am 11:00 am

Gross Appearance & Histology of Skin Cancer. Kyle Mannion M.D. January 21, 2005

Dual Wavelength Phototherapy System

Skin Cancer of the Nose: Common and Uncommon

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Non-melanoma Skin Cancer

See spot change: Lesion identification and management in primary care ERIN HENNESSEY DNP, APRN, FNP-C

Technicians & Nurses Program

Skin Cancers Emerging Trends and Treatment Approaches

Basal cell carcinoma 5/28/2011

Integumentary System

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Skin Cancer in Organ Transplant Recipients Challenges and Opportunities

Skin Care in Renal Transplant Patients

Have a Voice in Your Choice!

Healthy Skin Education in Alabama s Schools. Alabama Comprehensive Cancer Control Program

Sun Safety and Skin Cancer Prevention. Maryland Skin Cancer Prevention Program

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Skin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden

SKIN HISTOLOGY AND FUNCTION

Treatments used Topical including cleansers and moisturizer Oral medications:

Lid Lesions: Relax or Refer

MELANOMA. 4 Fitzroy Square, London W1T 5HQ Tel: Fax: Registered Charity No.

Case-Based Approach to Common Dermatologic Neoplasms

Integumentary System-Skin and Body Coverings

MELANOMA. Some people are more likely to get a m Melanoma than others:

Describe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function.

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

Principles of Anatomy and Physiology

SQUAMOUS CELL CARCINOMA

SEBACEOUS NEOPLASMS. Dr. Prachi Saraogi Clinical Fellow in Dermatology

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Cutaneous Adnexal Tumors

UV Spectrum Comprises 3 Ranges

Talking to Your Clients About Skin Cancer. Objectives 9/9/2017. Amanda Friedrichs, MD, FAAD AMTA National Conference September 14, 2017

SKIN HISTOLOGY the microscopic anatomy of the Integument. Mikrogeo. com

Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM

Chapter 05. Lecture Outline. See separate PowerPoint slides for all figures and tables pre-inserted into PowerPoint without notes.

Pathology. Skin Tumor. Bayan N. Mohammad 15/10/2015. Mohammad al-orjani. Page 0 of 23

Basal cell carcinoma

Preparing for Mohs Micrographic Surgery Tracy M. Campbell, M.D.

The Sun and Your Skin

Chapter 8 Skin Disorders and Diseases

Actinic Keratoses and Bowen s disease

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

All the Rest. What is All the Rest? Integumentary System. First are the FUNCTI0NS. THERMOREGULATION function. PROTECTION function 10/12/16

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

Transcription:

Malignant Cutaneous Neoplasms Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP All slides Kathleen Haycraft

Objectives: 1. Identify common cutaneous malignant neoplasms. 2. Identify the etiology, pathophysiology and treatment of common malignant cutaneous neoplasms. 3. Synthesize the information to identify common malignant cutaneous neoplasms. 4. Discuss pharmacologic management of common malignant cutaneous neoplasms.

Disclosures The speaker has no conflict of interest relevant to this topic

Actinic Keratosis AK Thick crusty, erythematous scale Kathleen Haycraft

Pigmented Actinic Keratosis Kathleen Haycraft

Etiology/Pathophysiology More likely Over 40, more common in men. Have a history of frequent or intense sun exposure or sunburn. Have pale skin, red or blond hair, and blue or light-colored eyes. Progressively lower incidence in Fitzpatrick1-5, almost nonexistent in 6. Personal history of an actinic keratosis or skin cancer.

Etiology/Pathophysiology Have a weak immune system as a result of chemotherapy, chronic leukemia, AIDS or organ transplant medications. If not treated they have a 20% chance of conversion to SCC. A skin biopsy to confirm the diagnosis and rule out invasive squamous cell carcinoma for suspicious or more advanced lesions (hyperkeratosis, increased erythema, or induration or nodularity) or if they are recurrent that did not respond to therapy. UV-induced mutations in key genes, including TP53 and deletion of the gene coding for p16 tumor suppressor protein.

Etiology/Pathophysiology Dysplasia and architectural disorder of the epidermis. Abnormal keratinocytes of the basal layer, variable in size and shape Altered cellular polarity Nuclear atypia Hyperkeratosis/parakeratosis of the epidermis Irregular acanthosis may be present In general, hair follicles, sebaceous glands, and apocrine and eccrine ducts are not involved

Appearance Small red, brown, flesh colored, pink, or white scaly patches that do not go away. Distribution pattern on face, ears, scalp, hands, but may occur anywhere. May be numerous and coalesce. If they itch, are tender, or bleed they need to be biopsied.

Treatment Cryotherapy. Photodynamic Therapy after treatment with ALA (Levulon) that activates the light in the AK to destroy the lesion. Electrodessication and curettage. Shave biopsy to treat and assess that it has not converted. Chemical peels

Treatment Laser resurfacing. Topical agents such as 5-FU (Effudex, Carac both may increase nodular BCC), Imiquimod (Aldara, Zyclara), Picato, and diclofenac (Solaraze, Voltaren) gel, AK is a field disease and needs to be treated as such: Cryo PDT the area Cryo Topical agents.

Discuss Prevention UVA, UVB, UVC waves. Ultraviolet rays are electromagnetic radiation with a wave length less than that of visible light. UVA penetrate deeply into the dermis and subcutaneous tissue (may easily penetrate glass). UVB penetrate into the epidermis and upper dermis. UVC usually bounce off the ozone layer. UVA waves are associated with autoimmune disease.

Prevention UVA, UVB, and UVC can all damage collagen and accelerate aging UVA and UVB destroy Vitamin A in the skin further damaging collagen and accelerating photo-aging. UVA was not recognized to be as harmful but it creates many oxygen free radicals which cause further DNA damage UVA is immunosuppressive. Because UVA is not measured by most SPF testing there is no good measurement for UVA protection. According to the Skin Cancer Foundation Even if it s not hot outside, 50 to 80 percent of UV rays still burn right through the clouds.

Prevention UVA is immunosuppressive. Because UVA is not measured by most SPF testing there is no good measurement for UVA protection. According to the Skin Cancer Foundation Even if it s not hot outside, 50 to 80 percent of UV rays still burn right through the clouds.

Prevention UVA waves give a quicker tan but a non-protective tan. UVB waves take about two days to begin to create a tan but the tan is protective. However, the production of melanin by UVB is called melanogenesis and direct DNA damage occurs. Melanogenesis increases the risk of cutaneous carcinoma.

Prevention Broad rimmed UV hat. Broad rimmed sunglasses. Avoid mid day sun. Wear sunscreen daily. Avobenzone, Zinc and Titanium Oxide reduce UVA. Think of the bucket theory with sunscreen.

Clinical Pearl If it is itchy or tender biopsy it. Remember that actinic keratosis is a field disease and needs to be treated as such. Nothing like MOHS on a patient with BCC or SCC that has been recurrently treated you may be there for 6 or more stages. Recent study shows if severe hypertension post PDT, likely to have BCC.

Basal Cell Cancer Crusted, ulcerated, bleeds easily Kathleen Haycraft

BCC Kathleen Haycraft

Nodular Basal Cell Cancer Slowly developed, bleeding, papule that has been there Kathleen Haycraft

Superficial Basal Cell Cancer Pink patch of skin that has been there Kathleen Haycraft

Pigmented BCC Susan Voss

Etiology/Pathophysiology Most common skin cancer. Represent 90% of cutaneous carcinoma. Almost never metastasize but can cause significant local destruction. Risk factors include: low Fitzpatrick score, sun exposure, weakening of the immune system by disease or medication. 3 in 10 Caucasians will develop a BCC in their lifetime.

Appearance Appears as a small, dome shaped bump covered with telangectasias. It may appear pearl like or shiny/translucent. They are usually somewhat firm to the touch. Appear as a pimple that comes and goes or comes and stays or a patch that comes and goes or comes and stays.

Types of BCC Superficial BCC Nodular BCC Pigmented BCC Cystic BCC Infiltrative BCC Morpheaform Micronodular BCC

Types of BCC Nevoid Basal Cell Carcinoma Syndrome also known as Gorlin syndrome.

Treatment Shave Biopsy to determine diagnosis but all biopsies that involve skin cancer require excision or other treatment beyond the biopsy even if margins are negative. EDCT Topical Excision

Treatment MOHS Topical Imiquimod, Picato under aluminum disc Radiation therapy PDT with photosensitizer (ALA) Erivedge (vismodegib)

Pearls If a BCC occurs at a site where you have had recurrent cryo always MOHS. The pimple or patch that comes and goes.

Squamous Cell Cancer Crusted scale, ulcerated, rapidly developed Kathleen Haycraft

Squamous Cell Cancer Thick scale, itchy, and slightly painful. Been there 1 year P r e v i Kathleen Haycraft

Squamous Cell Cancer Kathleen Haycraft Red border with yellow scale Has had kidney transplant and immune supressed

Kathleen Haycraft

Etiology/Pathophysiology Second most common. Rarely fatal except in transplant and immune compromised patients where mortality can exceed 20%. Linked to alcohol, HPV, and tobacco as well as UV. Unlike BCC, SCC more linked to chronic rather than intense intermittent UV exposure. PUVA is a risk factor.

Etiology/Pathophysiology Histologically unique uncontrolled proliferation of squamous cells (presence of keratin, desmosomes, and/or tonofilament bundles into dermis and surrounding tissues. Squamous cell in situ the tumor has not penetrated the basement membrane. Bowens is UV induced and is an early form of SCC. Keratocanthoma is rapidly growing. One method to identify a SCC is by its appearance under the microscope.

Appearance An ulcer or plaque with scaling, ulceration, and/or crusting. Frequently on sun exposed skin. May present as a cutaneous horn (height greater than width). Peri-neural involvement is associated with pain, numbness, change in vision, or muscle twitching.

Treatment Surgical excision. MOHS EDCT on low risk lesions, low risk sites, and low risk patients. Radiation. If patients have invasive SCC, on high risk areas, in high risk patients consider imaging for metastasis first.

Pearls If the height of a cutaneous horn exceeds the width is is more apt to be benign. If more than 50 % of the base of a lesion is erythematous it is more likely to be a BCC. Immune compromised patients are at high risk for metastasis and may need imaging prior to treatment.

Melanoma New lesion, dark and asymmetric Kathleen Haycraft

Melanoma When you see it with a derm-llite it is so easy Kathleen Haycraft

Nodular Melanoma Kathleen Haycraft

Melanoma upper arm referred Kathleen Haycraft

Other melanoma on same patient with FSE Kathleen Haycraft

Melanoma Kathleen Haycraft

Dermlite melanoma Kathleen Haycraft

Melanoma Chest Kathleen Haycraft

Dermlite melanoma Kathleen Haycraft

Kathleen Haycraft

Kathleen Haycraft

Lentigo Maligna Melanoma Chronically UV exposed skin Peppering Changing small structures Kathleen Haycraft

Etiology/Pathophysiology Melanoma is a malignancy arising from the melanocyte. Less common than basal or squamous but results in 75% of the deaths from cutaneous carcinoma. Caused by damage to the DNA by UV rays. Genetic links with BRAF, MEK, CDND2A. Genetic risk is higher with associated BRCA mutations. Eumelanin is more protective than pheomelanin

Appearance May appear as Asymmetric Irregular border Black, gray, blue, red, white or multiple colored lesion White veil Greater than 6 mm diameter Evolving Nodular elevated, firm, and growing.

Treatment Biopsy properly. Treatment indicated by: Breslow depth (Clark value with thin areas) Ulceration Mitotic Index Other factors Surgery, SLNB, chemotherapy, radiation, interferon, and vaccine. Lentigo maligna is a field disease.

Dysplasia, mild, moderate, severe, Clark s etc. Kathleen Haycraft Asymmetric It is getting bigger Irregular Border Dark Black 6mm

Severe Dysplasia This was a severe

What do you do with this? Kathleen Haycraft

Moderate Dysplasia Kathleen Haycraft

Etiology/Pathophysiology Atypical nevi (Dysplastic nevi). Atypical to the eye and dysplastic to the microscope. Some atypical nevi become melanoma but the majority do not. Roughly half of melanomas arise in these dysplastic nevi whereas the other half arise de novo. Melanomas can occur on sun or non-sun exposed sites.

Etiology/Pathophysiology Cytological atypia is of more significance than architectural atypia. Individuals with dysplastic nevus syndrome have an associated CDKN2A gene defect. If 5 or more, 10 times increased risk of melanoma.

Presentation ABCDE are helpful with these nevi. Ugly duckling the pretty duckling what doesn t belong with the rest. Cutaneous melanoma. Acral melanoma. Uveal melanoma.

Treatment Individuals with multiple dysplastic nevi should be monitored in a dermatology setting annually. Some dermatologists excise all, some monitor, our system is: Mild.Monitor Moderate.Excise with 2 mm margin Severe Excise with 9 mm margin

Merkel Cell Cancer Asymptomatic Kathleen Haycraft Pink violaceous plaques Associated telangectasias

Merkel Cell Cancer Kathleen Haycraft He was covered with these before death

Etiology/Pathophysiology Merkel cell carcinoma (cutaneous neuroendocrine tumor) is a malignant solid tumor derived from the Merkel cell. The Merkel cell is a mechanoreceptor that is present in the basal layer of the epidermis and surrounds the hair follicles. The tumor usually presents as a solitary lesion on the head or neck but may present as multiple lesions and on any area. The incidence of Merkel cell carcinoma (MCC) in the United States is approximately 1500 cases per year 1. As of 2005, the disease incidence had more than tripled over the previous 20 years 1.

Etiology/Pathophysiology There is an association of MCC with the polyomavirus (MCPyV). Eighty percent of MCC are infected with the virus versus 20% skin not involved with MCC. Studies confirm that MCC patients who harbor the MCPyV have a better prognosis then those who do not.

Appearance The tumor usually presents as a solitary lesion on the head or neck but may present as multiple lesions and on any area. A = Asymptomatic. E = Expanding rapidly. I = Immune suppressed. O = Older than 50 years. U = UV-exposed skin.

Appearance MCC Occurs in the elderly (greater than 65 years of age), male, immunosuppression and fair- skinned patients with chronic UV exposure. generally presents as a rapidly growing, non-tender, erythematous to violaceous nodule that has a shiny appearance. It is generally associated with overlying telangectasias.

Treatment Contrasted to melanoma with an average 5 year 15% mortality rate, MCC has a 49%. With proper staging this can increase to 79% survival rate with proper staging and treatment. There is a 4 tiered system for treatment selection that ranges from excision, SLNB, chemotherapy, radiation, or supportive care.

Mycosis Fungoides Kathleen Haycraft Patch Slightly pruritic Has been treated and never gets better

Etiology/Pathophysiology Cutaneous T-cell Lymphoma. Etiology is unclear. over 20 years of age, and it is more common in men than women. Common in sites covered with underwear. Unusual expression of CD4 T cells. May progress to Sezary syndrome 3:100,000.

Presentation Rashes, patches, or tumors that are pruritic in 20% of the cases. Frequently resembles eczema. May take many years and many biopsies to diagnose.

Treatment Depends on stage: Many never progress and rely on UVB and topical steroids. Sezary Zolinza (vorinostat) and other chemotherapies.

References Bolognia, Jean L., Jorizzo, Josep L., & Shaffer, Julie V. (2012). Dermatology: 2-Volume Set: Expert Consult Premium Edition (3 rd ed). Philadelphia, PA: Saunders. DermNet NZ: the dermatology resource. (2013). Retrieved from http://www.dermnetnz.org/ Fitzpatrick, James E., Morelli, & Joseph G. (2011). Dermatology Secrets Plus (4th Ed ed.). Philadelphia, PA: Mosby. Habif, Thomas B. (2009). Clinical Dermatology (5th ed.). Philadelphia, PA: Mosby. Medscape Reference: Drugs, Diseases, and Procedures. (2013). Retrieved from http://reference.medscape.com/ James, William D., Berge, Timothy, & Elston, D. (2011). Andrews' Diseases of the Skin, 11th Edition (11th ed.). Philadelphia, PA: Saunders. Wolf, K., & Johnson, R. A. (2013). Fitzpatricks Color Atlas and Synopsis of Clinical Dermatology (7th Ed. ed.). Columbus OH: McGraw Hill.

Let s Have Some Fun Tired of ideas of laser and filler His face lift Kathleen Haycraft

Kathleen Haycraft

Asymptomatic, Evolving Kathleen Haycraft

Getting darker Kathleen Haycraft

Slowly getting bigger Kathleen Haycraft

Got bigger quickly Kathleen Haycraft

Slowly evolving pink patch Kathleen Haycraft

Crusty and itchy been there awhile Kathleen Haycraft

Little pimple that won t go away Kathleen Haycraft

Crusty area keeps bleeding Kathleen Haycraft

Favorite Sites Websites for patients and providers: http://www.mayoclinic.com/health/diseasesindex/diseasesindex http://emedicine.medscape.com/dermatology http://www.nlm.nih.gov/ http://www.dermnetnz.org/sitemap.html Wolf, K., & Johnson, R. A. (2013). Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology (7th Ed. ed.). Columbus OH: McGraw Hill.